LIVZON PHARMA - Announcement of the resolution of the third holders meeting of the second phase of the medium and long-term business partner stock ownership plan of Livzon Pharmaceutical Group Co., Ltd.
LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement.
We accept no liability for any loss caused by reliance on such content.
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange Announcement of Resolutions of the Third Holders’ Meeting of the Second Phase of the Medium and Long-term Business Partner Stock Ownership Plan of the Company”, only
For reference.
By order of the board of directors Livzon Pharmaceutical Group Co., Ltd.
LivzonPharmaceuticalGroupInc.* company secretary Liu Ning
China, Zhuhai April 23, 2026
As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo. Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not
The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.
*Identification only
Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement number: 2026-36
Livzon Pharmaceutical Group Co., Ltd.
The second phase of the medium- and long-term business partner stock ownership plan
Announcement of Resolutions of the Third Holders’ Meeting
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, complete and not false. records, misleading statements or material omissions.
- Convening of shareholders’ meeting
Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") medium and long-term business partner shareholding plan
The third holders' meeting of the planned second phase of the share ownership plan (hereinafter referred to as the "second phase of the share ownership plan") will be held in 2026
The meeting was held on April 22, 2016 by communication voting. 78 holders should be present at this meeting, but actually attended the meeting
There are 70 people, representing 56,390,028 shares of the second-phase shareholding plan, accounting for the total number of shares of the company’s second-phase shareholding plan.
86.80% of the share. The convening, holding and voting procedures of this meeting complied with the "Livzon Pharmaceutical Group Co., Ltd. Co., Ltd.'s Medium and Long-term Business Partner Stock Ownership Plan - The Second Phase of the Stock Ownership Plan (Revised Draft)" "Livzon Pharmaceutical Collection"
Measures for the Administration of the Second Phase of the Medium- and Long-term Business Partner Stock Ownership Plan of Tuan Co., Ltd. (Revised
According to the provisions of the draft) and relevant laws and regulations, the resolutions formed at the meeting are legal and valid.
- Review and voting status of the holders’ meeting
This meeting reviewed and approved the following proposals by registered vote:
(1) Consideration and approval of the "Proposal on Changing the Members of the Management Committee of the Second Phase Stock Ownership Plan"
In view of the fact that Mr. Tang Yanggang, Ms. Si Yanxia, and Yang Liang, the original members of the management committee of the company’s second phase share ownership plan, Mr. resigned from his position as a committee member due to job changes, retirement, personal development and other reasons. In order to ensure the smooth progress of the current shareholding plan,
To ensure profitable operation, the company agreed to by-elect Mr. Liu Daping, the company’s president, Ms. Liu Ning, secretary of the board of directors, and Wang Sheng, chief financial officer.
Mr. Wang serves as a member of the Management Committee of the Second Phase Share Ownership Plan, and his term is consistent with the duration of the Second Phase Share Ownership Plan.
The above-mentioned proposed personnel do not hold positions in the company's controlling shareholders or actual controllers, and are not related to those who hold more than 5% of the company.
There is no related relationship between the shareholders, actual controllers and other directors and senior managers of the listed shares.
Voting results: 56,390,028 shares were approved, accounting for the total shares held by holders present at the meeting
100.00%%; 00,000 votes against, accounting for 0%; 00,000 votes abstaining, accounting for 0%.
(2) Consideration and approval of the "Proposal on Adjusting the Relevant Content of the Second Phase of the Stock Ownership Plan and Extending the Duration Period"
Revision of terms: Amend the terms of the extension of the duration in the second phase of the share ownership plan and management measures and delete them.
Except for the constraint of "within 10 days before the expiration of the duration". The revised terms are: "The current shareholding plan continues If all the shares are not sold before the expiration of the term, it shall be approved by more than 2/3 of the valid voting rights present at the holders' meeting, and
Upon review and approval by the board of directors, the duration of this share ownership plan can be extended."
Extension of the duration: In view of the fact that the duration of the second phase of the employee stock ownership plan is about to expire, based on the company's future Confidence in development, in order to effectively play the purpose and incentive role of the implementation of the employee stock ownership plan, it is agreed that the second phase of the stock ownership plan will be
The duration of the stock plan has been extended by 12 months to August 12, 2027.
Except for the above adjustments, other contents of the current share ownership plan remain unchanged.
Voting results: 56,390,028 shares were approved, accounting for the total shares held by holders present at the meeting
100.00%%; 00,000 votes against, accounting for 0%; 00,000 votes abstaining, accounting for 0%.
The proposal still needs to be submitted to the company's board of directors for review.
- Other instructions
The resolutions of this shareholders meeting are in compliance with the "Guidance on the Implementation of Pilot Employee Stock Ownership Plans by Listed Companies"
Opinions" Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations of Main Board Listed Companies
"Operation" and relevant documents of the company's stock ownership plan, the review process is legal and compliant. The company will continue to perform in accordance with regulations Information disclosure obligations, investors are advised to pay attention to subsequent announcements and be aware of investment risks.
- Documents available for inspection
Resolution of the third holders meeting of the second phase of the company's medium and long-term business partner stock ownership plan.
Announcement is hereby made.
Board of Directors of Livzon Pharmaceutical Group Co., Ltd.
April 24, 2026